This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Related articles in JOP Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Blayney, D. W. Search for Related Content PubMed Articles by Blayney, D. W.

Because this article has no abstract, we have provided an extract of the first 100 words of the full text.

Douglas W. Blayney, MD

I recently had occasion to review the charges associated with treatment for one of my patients. We are planning for one year of a biologic therapy in addition to chemotherapy because new data have changed the standard of care for early-stage breast cancer. At the University of Michigan (Ann Arbor, Michigan) the charge for this treatment would be more than $100,000—an astounding amount. Although this patient has third-party coverage, the day is likely to come when both public and private third-party payers will say that a cost of this magnitude is not supportable. Yet the evidence . . . [Click for More]

Related articles in JOP:

Electronic Health Records

Edward P. Ambinder
JOP 2005 1: 57-63. [Extract] [Full Text]